Evidence map›Paper›PMID 37104344›Full record

ArticleTropical medicine and infectious disease2023

Hepatitis B Prevalence among Men Who Have Sex with Men in Brazil.

Ana Rita C Motta-Castro, Lígia Kerr, Carl Kendall, Rosa S Mota, Mark Drew C Guimarães, Andréa Fachel Leal, Edgar Merchan-Hamann, Inês Dourado, Maria Amélia Veras, Ana Maria de Brito and 13 more

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 15 institutions in 2 countries.

Ana Rita C Motta-CastroFaculdade de Ciências Farmacêuticas, Alimentos e Nutrição, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.
Lígia KerrSaúde Comunitária, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza 60020-181, CE, Brazil.
Carl KendallSaúde Comunitária, Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza 60020-181, CE, Brazil.
Rosa S MotaDepartamento de Estatística e Matemática Aplicada, Universidade Federal do Ceará, Fortaleza 60020-181, CE, Brazil.
Mark Drew C GuimarãesMedicina Preventiva e Social, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
Andréa Fachel LealDepartamento de Sociologia, Universidade Federal do Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil.
Edgar Merchan-HamannFaculdade de Ciências da Saúde, Saúde Coletiva, Universidade de Brasília, Brasília 70910-900, DF, Brazil.
Inês DouradoInstituto de Saúde Coletiva, Universidade Federal da Bahia, Salvador 40170-110, BA, Brazil.
Maria Amélia VerasDepartamento de Saúde Coletiva, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo 01224-001, SP, Brazil.
Ana Maria de BritoDepartamento de Saúde Coletiva, Fiocruz: Instituto de Pesquisas Aggeu Magalhães, Universidade Federal de Pernambuco, Recife 50740-465, PE, Brazil.
Alexandre Kerr PontesInstituto de Psicologia da Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-901, RJ, Brazil.
Raimunda Hermelinda M MacenaFaculdade de Medicina, Universidade Federal do Ceará, Fortaleza 60020-181, CE, Brazil.ORCID 0000-0002-3320-8380
Daniela KnauthDepartamento de Medicina Social, Universidade Federal do Rio Grande do Sul, Porto Alegre 90010-150, RS, Brazil.
Luana N G C LimaInstituto Evandro Chagas, Ananindeua 67030-000, PA, Brazil.
Socorro CavalcanteSecretaria de Saúde do Estado do Ceará, Fortaleza 60060-440, CE, Brazil.
Ximena P Díaz-BermúdezCentro de Ciências da Saúde, Universidade de Brasília, Brasília 70910-900, DF, Brazil.
Lisangela C OliveiraEscola de Saúde, Centro Universitário Autônomo do Brasil UNIBRASIL, Curitiba 82820-540, PR, Brazil.
Laio MagnoDepartamento de Ciências da Vida, Universidade do Estado da Bahia (UNEB), Salvador 41150-000, BA, Brazil.ORCID 0000-0003-3752-0782
Ana Cláudia CamilloFundação Alfredo da Mata, Centro de Aconselhamento, Manaus 69065-040, AM, Brazil.
Marcílio F LemosLaboratório de Hepatites, Centro de Virologia, Instituto Adolfo Lutz, São Paulo 01246-000, SP, Brazil.
Vanessa Cristina M SilvaLaboratório de Hepatites, Centro de Virologia, Instituto Adolfo Lutz, São Paulo 01246-000, SP, Brazil.
Adriana P CompriLaboratório de Hepatites, Centro de Virologia, Instituto Adolfo Lutz, São Paulo 01246-000, SP, Brazil.
Regina Célia MoreiraLaboratório de Hepatites, Centro de Virologia, Instituto Adolfo Lutz, São Paulo 01246-000, SP, Brazil.ORCID 0000-0002-8208-8776
Instituto Adolfo Lutz · BRUniversidade Federal do Ceará · BRUniversidade de Brasília · BRUniversidade Federal do Rio Grande do Sul · BRFaculdade de Ciências Médicas da Santa Casa de São Paulo · BRInstituto Evandro Chagas · BRSecretaria da Saúde · BRTulane University · USUniBrasil Centro Universitário · BRUniversidade do Estado da Bahia · BRUniversidade Federal da Bahia · BRUniversidade Federal de Mato Grosso do Sul · BRUniversidade Federal de Minas Gerais · BRUniversidade Federal de Pernambuco · BRUniversidade Federal do Rio de Janeiro · BR

Funding

Ministry of Health Project # 914BRZ1138, BRAZIL, AIDS-SUS
6 · The paper itself

Abstract

Hepatitis B virus (HBV) is a global public health problem and requires specific prevention actions, particularly focusing on the key populations, such as men who have sex with men (MSM). We aimed at assessing the prevalence of HBV infection, among MSM, in a multicity study in Brazil. In 2016, we conducted a survey using a respondent-driven sampling methodology in 12 Brazilian cities. Rapid tests (RT) were performed on 3178 samples from those MSM. Positive results were tested for HBV DNA and sequenced. If negative for HBV DNA, samples were tested for serological markers. The prevalence rate of HBV exposure and clearance was 10.1% (95% CI: 8.1-12.6), and 1.1% (95%; CI: 0.6-2.1) were confirmed to be HBsAg-positive. Of those samples tested for anti-HBs (

Indexed as

hepatitis B virusMSMrespondent-driven sampling

Identifiers

PMID37104344
PMCPMC10142294
OpenAlexW4362673356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.